[ Price : $8.95]
FDA posts updated definitions of face-to-face meeting formats to the PDUFA 7 and BsUFA 3 Web pages.[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Cross Labeling Oncology Drugs in Combination Regimens.[ Price : $8.95]
Federal Register notice: FDA requests comments on the topics discussed at its 9/14 public workshop entitled Advancing Premarket Sa...[ Price : $8.95]
FDA and academic researchers present a framework to include transgender people in clinical trials.[ Price : $8.95]
FDA issues a safety alert warning parents and caregivers not to use infant head shaping pillows intended to change an infants head...[ Price : $8.95]
FDAs Pharmaceutical Science and Clinical Pharmacology Advisory Committee unanimously votes to recommend that CDER move forward wit...[ Price : $8.95]
FDA posts PDUFA 7 updates to the model-informed drug development paired meeting program.[ Price : $8.95]
GSK stops enrollment early due to positive results two Phase 3 trials evaluating gepotidacin, an investigational drug for uncompli...